Low-tech, minimally invasive localized brain drug delivery system
Elisa Konofagou, Ph.D.
Utilizes intermediate frequencies to minimize damage to non-target regions and ultrasound aberrationsMRI-independent targeting and verificationMore compact than conventional technology allowing portability and increasing patient base to non-specialized clinical settings (e.g., outpatient clinics; community hospitals).Utilizes a single transducer setup, reducing the cost and targeting uncertaintyPatent information:Patent Pending (WO/2011/153268Tech Ventures Reference: IR CU14052
Safe and reliable method to open the BBB in specific, shallow, or deep-seated brain regionsSpatially specific neuroscience research in a laboratory settingMay be adapted to improve accessibility and spatial resolution of ultrasound-hemostasis, -lithotripsy, and -assisted thrombolysis.May be adapted for non-invasive research of structures
Elisa Konofagou, Ph.D.
美國
